Insight

An update on the development of HER2-targeted therapies

Photo taken from ghealth121.com

Jul 25, 2024, 01:39

An update on the development of HER2-targeted therapies

Elisabetta Bonzano, Radiation Oncologist at IRCCS San Matteo Polyclinic Foundation, shared on X:

“HER2-targeted therapies beyond breast cancer – an update on Nature Reviews Clinical Oncology an update on the current development landscape of HER2-targeted therapies, as well as anticipated future HER2-directed treatment strategies to overcome resistance and thereby improve efficacy and patient outcomes.”

HER2-targeted therapies beyond breast cancer – an update | Nature Reviews Clinical Oncology

Autors: Jeesun Yoon and Do-Youn Oh

HER2-targeted

Source: Elisabetta Bonzano/X

Breast Cancer cancer Do-Youn Oh Elisabetta Bonzano HER2-targeted therapy Jeesun Yoon Nature Reviews Clinical Oncology OncoDaily Oncology radiation oncology

Oncologist Near Me - Vivek Subbiah: Pionner of Precision Oncology

Monica Bertagnolli is ending her tenure as NIH director

NEW PAPER ALERT: Efficacy of CDK4/6 Inhibitors and Endocrine Therapy in HR+/HER2- Advanced Breast Cancer by PAM50 Subtype: SOLTI-1801 CDK-PREDICT Results

Oncologist Near Me – Fabrice André: Leading Expert in Breast Cancer

Funding Impactful Cancer Research That Might Otherwise Go Unsupported: Ryan Schoenfeld on the Secret Behind Mark Foundation’s Success

Special Coverage